Dyve Biosciences and Moffitt Report Promising Cancer Therapy Results

Novel topical treatment aims to boost immune response and slow tumor growth.

Apr. 14, 2026 at 4:32pm

Got story updates? Submit your updates here. ›

An extreme close-up X-ray photograph showing the complex internal structure of a cancerous tumor, with faint red highlights suggesting the therapy's potential to disrupt the tumor's acidic environment.A novel topical therapy targeting the acidity of cancer tumors aims to boost the immune system's ability to recognize and attack malignant cells.Camarillo Today

Dyve Biosciences, in collaboration with Moffitt Cancer Center, has reported promising early study results for a novel topical therapy that targets tumor acidity, a major barrier preventing the immune system from fighting cancer effectively. The therapy showed the ability to boost immune response and slow tumor growth in initial studies, pointing to a potential breakthrough treatment approach.

Why it matters

Tumor acidity is a significant challenge in cancer treatment, as it can prevent the immune system from properly recognizing and attacking cancer cells. This new topical therapy represents a novel approach to addressing this issue and potentially improving outcomes for cancer patients.

The details

The therapy works throughout the body to target tumor acidity, a key factor that can inhibit the immune system's ability to fight cancer. Early studies demonstrated the therapy's ability to boost immune response and slow tumor growth, suggesting it could be an important new tool in the fight against cancer.

  • The study results were reported on April 14, 2026.

The players

Dyve Biosciences

A biopharmaceutical company developing novel therapies, including this topical treatment targeting tumor acidity.

Moffitt Cancer Center

A leading cancer research and treatment institution that collaborated with Dyve Biosciences on the studies for this new therapy.

Got photos? Submit your photos here. ›

What’s next

The companies plan to continue further clinical studies to evaluate the therapy's safety and efficacy, with the goal of potentially bringing this novel treatment approach to cancer patients.

The takeaway

This new topical therapy targeting tumor acidity represents a promising breakthrough in the fight against cancer, as it aims to overcome a key barrier that has historically prevented the immune system from effectively recognizing and attacking cancer cells.